Log in to save to my catalogue

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7938381

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

About this item

Full title

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2019-11, Vol.25 (11), p.1715-1720

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Functional diversity of the highly polymorphic human leukocyte antigen class I (
HLA
-I) genes underlies successful immunologic control of both infectious disease and cancer. The divergent allele advantage hypothesis dictates that an
HLA
-I genotype with two alleles with sequences that are more divergent enables presentation of more div...

Alternative Titles

Full title

Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7938381

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7938381

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-019-0639-4

How to access this item